Standard therapy | Clinical trials | Preclinical | Total | Number of TCGA samples | Databases used by the study | ||||
---|---|---|---|---|---|---|---|---|---|
Label | Off-label | Label | Off-label | Label | Off-label | ||||
MTB | 9.9 (A1) | 22.7 (B1) | 64.1 (A2) | 89 (B2) | 90.6 (A3) | 94.1 (B3) | 94 | 3184 | GDKD, CIViC, TARGET |
Dienstmann et al. 2015 [20] | 11 (5) | – | 39 (4) | 75 (3) | 93 (1-2) | 93 | 4392 | GDKD | |
Rubio-Perez et al. 2015 [19] | 5.9 | 40.2 | 73.3 | – | – | 73.3 | 4068 | Rubio-Perez et al. 2015 | |
Chakravarty et al. 2017 [18] | 7.5 (1–2A) | 16 (2B) | 26 (3A) | 41 (3B) | – | – | 41 | 5983 | OncoKB |